A 2-Week Exploratory Randomized, Double-Blind, Parallel-Group, Dose-Ranging, Placebo-Controlled Safety, Tolerability, Biomarker and Efficacy Clinical Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2018
At a glance
- Drugs Thykamine (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Proof of concept
- Sponsors PurGenesis Technologies
- 06 Aug 2013 A full report of the results of this trial is expected in the third quarter of 2013, according to a PurGenesis Technologies media release.
- 06 Aug 2013 Interim results published in a PurGenesis Technologies media release.
- 31 Mar 2012 Planned number of patients changed from 24 to 56 as reported by European Clinical Trials Database record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History